The Institute of Economic Affairs One of the most impressive examples of the dissemination of ideology through educational activities has been performed by the UK- based Institute of Economic Affairs (IEA), founded in 1955. Dedicated to the idea of free-markets the IEA from the beginning saw the "education" of the public as a key element in the distribution of their ideology. "The philosophy of the market economy must be widely accepted; this requires a large programme of education ..." Aiming at the wide acceptance of their ideas, the IEA undertook an extensive publishing program with the objective to make the fairly complex concepts of economic liberalism and monetarism available to a student or sixth-form audience. In the 1960s IEA papers normally reached the hands of students through the university Conservative Associations. The work that the IEA did in this field reaped a rich harvest during the 1970s and 1980s, as many of the younger political activists who staffed the various free-market think-tanks, such as the Center for Policy Studies, the Freedom Association an the Selsdon Group, received their education from the IEA. Especially at St. Andrews university, where Ralph Harris, the first director of the IEA, had been a lecturer, the IEA ideas had a strong impact. St. Andrews over the years did not only produce a generation of free-market Conservative MPs (Member of Parliament), but also influenced former St. Andrews students like Stuart and Eamonn Butler and Madsen Pirie, who went to set up the Adam Smith Institute (ASI) in London in 1976.

TEXTBLOCK 1/1 // URL: http://world-information.org/wio/infostructure/100437611704/100438658264

Bristol-Myers Squibb Company American company resulting from a merger in 1989 and dating to companies founded in 1858 and 1887. It produces toiletries, cosmetics, household cleaning products, pharmaceuticals, health foods and supplements, and health equipment and prostheses. Headquarters are in New York City. In 1989 the merger of Bristol-Myers Company and Squibb Corporation (descendant of a company founded in 1858) created one of the world's largest pharmaceutical companies.

INDEXCARD, 1/1